Yokoyama T, Torisu M, Durst A L, Schroter G, Groth C G, Starzl T E
Surgery. 1972 Oct;72(4):611-8.
The whole serum complement and its components were studied in 24 recipients of 27 renal homografts. In 12 of 13 instances in which homograft rejection was diagnosed, it was accompanied by significant declines in CH50, IA50, C4, and C3 levels, and to a lesser degree in C1 and C2 levels. Fourteen patients had normal graft function during the postoperative course of study, and in 13 of the 14 the complement levels were within the normal range throughout. In two recipients with systemic lupus erythematosus, very low initial complement levels increased to normal levels following removal of the native kidneys, splenectomy, and the provision of a well-functioning homograft. Anticomplement activity and elevated titers of C1 and C3 inactivators were observed in some patients, but these did not correlate with the changes in CH50. The findings confirm that the complement system participates in renal homograft rejection.
对27例肾移植受者中的24例进行了全血清补体及其各成分的研究。在确诊为同种异体移植排斥反应的13例中的12例中,伴有CH50、IA50、C4和C3水平显著下降,C1和C2水平下降程度较小。14例患者在术后研究过程中移植肾功能正常,14例中的13例补体水平始终在正常范围内。在2例系统性红斑狼疮受者中,极低的初始补体水平在切除自身肾脏、脾切除并提供功能良好的同种异体移植后升至正常水平。在一些患者中观察到抗补体活性以及C1和C3灭活剂滴度升高,但这些与CH50的变化无关。这些发现证实补体系统参与了肾同种异体移植排斥反应。